A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Silverstein, MD
INTEGRIS Baptist Medical Center, Inc. Paul Silverstein Burn Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Burn Center
Phoenix, Arizona, United States
- Orlando Regional Medical Center
Orlando, Florida, United States
- Wishard
Indianapolis, Indiana, United States
- Paul Silverstein, Md
Oklahoma City, Oklahoma, United States
- S:t Christopher'S Hospital for Children
Philadelphia, Pennsylvania, United States
- Harborview Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 31 Aug 2013
- Completion
- 31 Aug 2013
- Last update posted
- 7 Oct 2014
- Registered enrollment
- 45
- Registry id
- NCT01636362
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.